Delivery Order SPE2DB22D3016-SPE2DB25FBDV9
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of TIVDAK 40 MG VIALS, a pharmaceutical product, to support military healthcare programs. The $13,083.75 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- AmerisourceBergen Drug Corp received a delivery order valued at $21,806.25 from the Defense Logistics Agency for 40 mg vials of TIVDAK, awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TIVDAK 40 MG VIALS. The $17,445.00 fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 3, 2025 with a completion date of July 25, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of TIVDAK 40 MG VIALS. The contract has a ceiling value of $11,956.29 and a completion date of October 10, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other federal healthcare providers. This contract is part of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,926.36 to AmerisourceBergen Drug Corp for TALVEY 40 mg/ml vials. This firm fixed-price, competitively awarded delivery order (Contract No. 4569329234) was issued on September 4, 2025, with an ultimate completion date of September 25, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVM13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,083.75 firm fixed-price delivery order is for the supply of 4,568,078,648 units of the drug TIVDAK 40 MG VIALS. The contract has a period of performance through May 20, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,907.08 to AmerisourceBergen Drug Corp for FOTIVDA (tivozanib) 1.34 mg capsules (21-count units) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the supply of TIVDAK 40 MG VIALS, a pharmaceutical product, with a ceiling value of $23,912.58 and a performance period through July 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- The Defense Logistics Agency awarded a $13,963.18 delivery order to AmerisourceBergen Drug Corp for Talvey 40 mg/ml vials under a firm fixed price contract type. This delivery order, with an ultimate completion date of June 27, 2025, represents a child contract issued against the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $47,268.96 for TUKYSA 150 mg tablets (120-count units) from the Defense Logistics Agency Medical Supply Chain. This competitive award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, carries firm fixed pricing and represents a non-set-aside delivery order. The contract is performed at the vendor's Conshohocken location...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDV9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,083.75 to AmerisourceBergen Drug Corp for the supply of Tivdak 40 mg vials, a chemotherapy medication. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement running through December 2026 that supplies comprehensive pharmaceutical and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran medical supply chains. The delivery order for Tivdak vials supports the Defense Health Agency and other government healthcare systems' oncology treatment requirements. As a non-set-aside award, the contract was competitively awarded and reflects the contractor's demonstrated capability to fulfill federal pharmaceutical procurement needs. The DLA's Troop Support Medical program leverages AmerisourceBergen's extensive distribution network and pharmaceutical inventory to ensure reliable access to specialized medications and medical supplies across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 8/4/25 |